# The DRAGON 2 Trial

> **NCT05428735** · NA · RECRUITING · sponsor: **Maastricht University** · enrollment: 348 (estimated)

## Conditions studied

- Colorectal Cancer Liver Metastases (CRLM)
- Small Future Liver Remnant (FLR)

## Interventions

- **PROCEDURE:** Embolization

## Key facts

- **NCT ID:** NCT05428735
- **Lead sponsor:** Maastricht University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 348 (ESTIMATED)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05428735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05428735, "The DRAGON 2 Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05428735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*